Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

Moderna Shares Rise on the Release of Positive Results from Two mRNA Phase 1 Programs

Shares of Moderna Inc. traded up double-digits today as the firm announced results from its Phase 1 CMV Vaccine Study as well as its Phase 1 data for mRNA-1944 encoding for antibody against the chikungunya virus. This morning clinical-stage biotechnology company Mode...
Streetwise Reports | September 13, 2019 |

Insmed Shares Trade 40% Higher on Phase 2 Top-Line Bronchiectasis Trial Data

Insmed Inc.'s shares traded higher today after the company reported positive top-line results from its Phase 2 WILLOW Study of INS1007 in patients with non-cystic fibrosis bronchiectasis. Global biopharmaceutical company Insmed Inc. (INSM:NASDAQ) , which is...
Streetwise Reports | February 4, 2020 |

Savara Shares Double After FDA Grants Breakthrough Therapy Status for aPAP Treatment

Shares of Savara opened nearly 140% higher today after the orphan lung disease company advised that the FDA has granted Breakthrough Therapy designation for the firm's Molgradex for treatment of Autoimmune Pulmonary Alveolar Proteinosis (aPAP). This morning orphan lun...
Streetwise Reports | January 2, 2020 |

How This Company is Putting the Spotlight on Rare Earths

Critical minerals are crucial to the future of renewable energy and clean energy applications, and companies like NioCorp Developments Ltd. (TSX:NB,OTCQX:NIOBF, Forum) are crucial to the...
Jocelyn Aspa | August 23, 2022 |

Ucore Rare Metals Looks to Shift the Focus From China to the US for REE Supply

Ucore Rare Metals Inc. (TSXV:UCU) is grabbing the mining industry by the horns thanks to its critical minerals separation technology and developing rare earth elements (REE) separation facility in Alaska.
John Ballem | August 25, 2021 |

Achillion Pharma Shares Open 75% Higher After Alexion Buyout Offer

Shares of Achillion Pharmaceuticals are trading much higher today after the firm reported that it has agreed to be acquired by Alexion Pharmaceuticals for $930 million, or $6.30 per share in cash, along with the potential for an additional $2 per share if certain other specifi...
Streetwise Reports | October 17, 2019 |

Rally ahead for Molycorp (MCP) and rare earth stocks?

Rare earth stocks such as Molycorp ( NYSE: MCP , Stock Forum ) were all the rage with investors in early 2011. The Market Vectors Rare Earths Strategic Metals ETF ( AMEX: REMX , Stock Forum ) hit its 52-week high of $28.91 per share in April. Molycorp stock, included ...
Justin Dove | October 28, 2012 |

Coronavirus Propels Telemedicine into the Spotlight

Summary: Coronavirus could be the game changer that propels telemedicine into the mainstream. Virtual clinical services have been around since the '90s but had failed to catch on. Now, a concerted effort by healthcare providers, insurance companies, the federal government...
Streetwise Reports | March 27, 2020 |

America's rare earth rush could cause these stocks to pop

Share | Okay, so the stock market has gone nowhere this year. In fact, it’s gone nowhere in 10 years. But that doesn’t mean all the money-making opportunities have dried up. Investors have had plenty of opportunities to make money in in...
Dr. Mark Skousen | October 28, 2012 |

Coronavirus China Infection Statistics Analysis, Probability Forecasts 1/2 Million Infected

We in the West are in still the CALM before the Coronavirus STORM stage, both in terms of infections and in terms of economic impact as we witness China's economy effectively grind to a halt, a harbinger of what to expect to come that the financial markets are STILL NOT disc...
Nadeem Walayat | February 24, 2020 |
1 2 3 4 5 6 7 8 9 10 ...